JPWO2021152201A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021152201A5 JPWO2021152201A5 JP2022542038A JP2022542038A JPWO2021152201A5 JP WO2021152201 A5 JPWO2021152201 A5 JP WO2021152201A5 JP 2022542038 A JP2022542038 A JP 2022542038A JP 2022542038 A JP2022542038 A JP 2022542038A JP WO2021152201 A5 JPWO2021152201 A5 JP WO2021152201A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- integer
- diseases
- values
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ESP202030070 | 2020-01-29 | ||
| ES202030070A ES2846824B2 (es) | 2020-01-29 | 2020-01-29 | Profarmacos de acidos grasos poliinsaturados y usos medicos de los mismos |
| EP20382145 | 2020-02-28 | ||
| EP20382145.9 | 2020-02-28 | ||
| ESP202031155 | 2020-11-17 | ||
| ES202031155A ES2911474B2 (es) | 2020-11-17 | 2020-11-17 | Profarmacos de acidos grasos monoinsaturados y sus metabolitos: usos medicos y como biomarcadores |
| PCT/ES2021/070068 WO2021152201A2 (es) | 2020-01-29 | 2021-01-28 | Metabolitos de ácidos grasos alfa-hidroxilados, usos médicos de los mismos y uso como biomarcadores |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023518640A JP2023518640A (ja) | 2023-05-08 |
| JPWO2021152201A5 true JPWO2021152201A5 (https=) | 2024-02-05 |
| JP2023518640A5 JP2023518640A5 (https=) | 2024-02-05 |
| JP7736313B2 JP7736313B2 (ja) | 2025-09-09 |
Family
ID=77078835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542038A Active JP7736313B2 (ja) | 2020-01-29 | 2021-01-28 | αヒドロキシル化脂肪酸代謝産物、その医学的使用およびバイオマーカーとしての使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230097753A1 (https=) |
| EP (1) | EP4098649A4 (https=) |
| JP (1) | JP7736313B2 (https=) |
| KR (1) | KR20220132552A (https=) |
| CN (1) | CN115052852A (https=) |
| AU (2) | AU2021212330A1 (https=) |
| BR (1) | BR112022015172A2 (https=) |
| CA (2) | CA3166307C (https=) |
| CL (1) | CL2022001985A1 (https=) |
| IL (1) | IL295120A (https=) |
| MX (1) | MX2022009035A (https=) |
| WO (1) | WO2021152201A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3105521A1 (en) | 2018-07-20 | 2020-01-23 | F. Hoffmann-La Roche Ag | Sulfonimidamide compounds as inhibitors of interleukin-1 activity |
| ES2982396A1 (es) * | 2023-03-14 | 2024-10-15 | Veritas Therapeutics S L | 2-hidroxi-octadecen-9-cis-oato para uso en el tratamiento de patologias oncologicas y del dolor neuropatico |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1147221B (de) * | 1958-06-28 | 1963-04-18 | Dr Rer Nat Gernot Grimmer | Verfahren zur Herstellung von entzuendungs- und oedemhemmenden Salzen der Pentadecen- und Heptadecensaeuren |
| DE1195296B (de) * | 1958-06-28 | 1965-06-24 | Dr Gernot Grimmer | Verfahren zur Herstellung von entzuendungs- und oedemhemmenden Salzen der cis-9-Pentadecensaeure und der cis-9-Heptadecensaeure |
| GB1156465A (en) * | 1967-02-16 | 1969-06-25 | Unilever Ltd | Prostaglandins |
| US5856537A (en) | 1996-06-26 | 1999-01-05 | The Scripps Research Institute | Inhibitors of oleamide hydrolase |
| GB9901809D0 (en) * | 1999-01-27 | 1999-03-17 | Scarista Limited | Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes |
| GB9926833D0 (en) * | 1999-11-15 | 2000-01-12 | Univ Sunderland | Compositions |
| DE102007055344A1 (de) * | 2007-11-19 | 2009-05-20 | K. D. Pharma Bexbach Gmbh | Neue Verwendung von Omega-3-Fettsäure(n) |
| ES2342997B1 (es) * | 2008-12-09 | 2011-06-06 | Universitat De Les Illes Balears | Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento. |
| ES2345241B1 (es) * | 2009-03-16 | 2011-09-08 | Lipopharma Therapeutics | Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos. |
| KR20120065276A (ko) | 2009-05-29 | 2012-06-20 | 뉴 챕터, 인코포레이티드. | 지질 조성을 조정하기 위한 조성물 및 방법 |
| CN102276444B (zh) * | 2011-05-04 | 2013-10-09 | 厦门大学 | 脂肪酸类化合物及其制备方法与应用 |
| ES2401629B1 (es) | 2011-10-07 | 2014-03-04 | Universitat De Les Illes Balears | Enantiómeros de 2-hidroxiderivados de ácidos grasos y su uso como medicamentos. |
| WO2014113584A1 (en) * | 2013-01-16 | 2014-07-24 | Rhode Island Hospital | Compositions and methods for the prevention and treatment of osteolysis and osteoporosis |
| US20150173410A1 (en) * | 2013-12-19 | 2015-06-25 | Change Cola, Inc. | Beverage comprising omega fatty acid |
| JP2016222590A (ja) * | 2015-05-29 | 2016-12-28 | 国立大学法人東京海洋大学 | 脂肪酸の同位体標識化合物の製造方法およびその方法により得られた脂肪酸の同位体標識化合物、ならびに診断薬 |
| WO2019241728A1 (en) * | 2018-06-15 | 2019-12-19 | Youhealth Biotech, Limited | Composition and methods for modulation of elovl2 |
-
2021
- 2021-01-28 CN CN202180011594.4A patent/CN115052852A/zh active Pending
- 2021-01-28 AU AU2021212330A patent/AU2021212330A1/en not_active Abandoned
- 2021-01-28 WO PCT/ES2021/070068 patent/WO2021152201A2/es not_active Ceased
- 2021-01-28 CA CA3166307A patent/CA3166307C/en active Active
- 2021-01-28 JP JP2022542038A patent/JP7736313B2/ja active Active
- 2021-01-28 BR BR112022015172A patent/BR112022015172A2/pt unknown
- 2021-01-28 MX MX2022009035A patent/MX2022009035A/es unknown
- 2021-01-28 EP EP21748005.2A patent/EP4098649A4/en active Pending
- 2021-01-28 IL IL295120A patent/IL295120A/en unknown
- 2021-01-28 US US17/759,782 patent/US20230097753A1/en active Pending
- 2021-01-28 KR KR1020227027634A patent/KR20220132552A/ko active Pending
- 2021-01-28 CA CA3233141A patent/CA3233141A1/en active Pending
-
2022
- 2022-07-21 CL CL2022001985A patent/CL2022001985A1/es unknown
-
2023
- 2023-10-13 AU AU2023248158A patent/AU2023248158B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020205213B2 (en) | Use of derivatives of polyunsaturated fatty acids as medicaments | |
| AU2024219827A1 (en) | Structurally enhanced fatty acids containing oxygen for treatment of non-alcoholic steatohepatitis | |
| JP2020519661A5 (https=) | ||
| RU99121849A (ru) | Терапевтические композиции | |
| JP5423905B2 (ja) | 新規化合物及びその医薬用途 | |
| KR20210116517A (ko) | 케타민 파모에이트 및 이의 용도 | |
| CN110099681A (zh) | 用于治疗口腔干燥症的组合物和方法 | |
| JP2021534160A5 (https=) | ||
| WO2022166599A1 (zh) | Pqq 及其衍生物的新应用 | |
| KR102567089B1 (ko) | 곰팡이 감염의 치료를 위한 조성물 및 방법 | |
| AU2015389862B2 (en) | Use of thia oxo compounds for lowering Apo C3 | |
| JPWO2021152201A5 (https=) | ||
| US11628163B2 (en) | 1-piperidinepropionic acid for treating a fibrosing disease | |
| CN109310669B (zh) | 氨基甲酸酯化合物用于预防或治疗三叉神经痛的用途 | |
| JP7417595B2 (ja) | てんかん重積状態の予防、軽減又は治療のためのカルバメート化合物の使用 | |
| JP2019535795A (ja) | 口腔感染症の処置のための組成物及び方法 | |
| JP2012520274A (ja) | 必須脂肪酸化合物 | |
| TWI555528B (zh) | 泛醇基二十二碳六烯酸酯及其於治療與預防心血管疾病的用途 | |
| KR870700065A (ko) | 신규한 카본산 에스테르 | |
| JP7705649B2 (ja) | 皮膚組織の異常を改善するための組成物 | |
| CN104177318A (zh) | L-抗坏血酸-6-（10-羟基-2-癸烯酸）酯或其衍生物以及它们的应用 | |
| JPWO2021009506A5 (https=) | ||
| KR20250004689A (ko) | 수크로스 이성질체와 함께 신남산 유도체로 이루어진 신규한 건강기능식품/치료 조성물 | |
| IL294186A (en) | Preparations containing dendrimers with anti-inflammatory activity for the treatment of psoriasis | |
| RU2024100816A (ru) | Новая соль 2-амино-2-(2-(1-децил-1h-1,2,3-триазол-4-ил)этил)пропан-1,3-диола и содержащая ее фармацевтическая композиция |